Emiko Nakamura
Direttore/Membro del Consiglio presso RIBOMIC INC.
Patrimonio netto: 168 952 $ in data 31/05/2024
Provenienza dei contatti di primo grado di Emiko Nakamura
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
20
| Public Company | Pharmaceuticals: Major | 20 |
RIBOMIC USA, INC.
 RIBOMIC USA, INC. Pharmaceuticals: MajorHealth Technology Part of Ribomic, Inc., Ribomic USA, Inc. develops aptamer therapeutics.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Emiko Nakamura tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ASTENA HOLDINGS CO., LTD. | Pharmaceuticals: Other | Director of Finance/CFO | |
| Aoyama Gakuin University | College/University | Undergraduate Degree | |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Medical Specialties | President | |
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
TMRC Co. Ltd.
 TMRC Co. Ltd. Medical/Nursing ServicesHealth Services TMRC Co. Ltd. provides contract research and manufactures medicines. It develops anti-cancer products and those for cancer associated disorders. The company was founded by Hisao Ekimoto in January 2002 and is headquartered in Tokyo, Japan. | Medical/Nursing Services | Director/Board Member | |
| Cardio, Inc. | Director/Board Member | ||
Daiwa Corporate Investment Co., Ltd.
 Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment Co. Ltd. (Daiwa Corporate Investment) is a private equity arm of Daiwa Securities Group Inc. and is headquartered in Tokyo, Japan. The firm was founded in 1982. | Investment Managers | Private Equity Investor | |
Santen Holdings U.S., Inc.
 Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Financial Conglomerates | Director/Board Member | |
| Upjohn Pharmaceuticals Ltd. | Corporate Officer/Principal | ||
| RAQUALIA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
J-Pharma Co., Ltd.
 J-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology J-Pharma Co. Ltd. develops pharmaceutical products. It develops therapeutics and diagnostic agents for treatment of cancer. The company was founded in 2005 and is headquartered in Yokohama, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Trans Chromosomics, Inc.
 Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Miscellaneous Commercial Services | Director/Board Member | |
Editforce, Inc.
 Editforce, Inc. Miscellaneous Commercial ServicesCommercial Services Editforce, Inc. engages in research, development and production of medicinal drugs. The company is headquartered in Fukuoka, Japan. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
| Giappone | 12 |
| Stati Uniti | 5 |
Settori
| Health Technology | 7 |
| Finance | 4 |
| Commercial Services | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 21 |
| Corporate Officer/Principal | 10 |
| Chief Tech/Sci/R&D Officer | 5 |
| Chief Administrative Officer | 5 |
| Comptroller/Controller/Auditor | 4 |
Contatti più connessi
- Borsa valori
- Insiders
- Emiko Nakamura
- Connessioni Società
